Orforglipron (12mg x 90 Capsules = 1,080mg)

$415.00

The Peptide Store offers Orforglipron in a precision-dosed oral capsule format, manufactured to ≥98% purity for advanced laboratory research into incretin pathway signaling and metabolic regulation. This 90-capsule configuration provides a substantial, reliable research supply engineered for high-dose metabolic flux studies and sustained glycemic control investigations. For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.

SKU: orforglipron-12mg-x-90-capsules-1-080mg Category:
Description

Product Overview

Orforglipron is a structurally distinct, non-peptide small-molecule GLP-1 receptor agonist that has attracted significant scientific interest for its oral bioavailability profile and incretin-mimetic pharmacodynamic properties. Unlike conventional peptide-based GLP-1 agonists, Orforglipron’s small-molecule architecture confers inherent resistance to enzymatic degradation by gastric proteases and intestinal peptidases, making it a compelling research tool for oral delivery simulation studies. The Peptide Store supplies this compound in a pre-measured 12mg capsule format across a 90-count configuration, providing research laboratories with an extensive, consistent baseline for long-term assay programming, metabolic flux tracking, and multi-subject preclinical cohort design.

Peptide Structure & Amino Acid Sequence

Orforglipron is classified as a non-peptide small molecule rather than a traditional amino acid chain, distinguishing it fundamentally from peptide-based GLP-1 receptor agonists such as semaglutide or liraglutide. Its low molecular weight and compact chemical scaffold enable oral administration without the structural vulnerabilities associated with polymeric peptide sequences. This architecture eliminates the need for subcutaneous delivery routes in research contexts and opens new investigative avenues into orally active incretin receptor modulation at the molecular level.

Chemical & Physical Characteristics

  • Classification: Non-peptide small-molecule GLP-1 receptor partial agonist
  • Administration Route (Research Context): Oral capsule
  • Unit Dose: 12mg per capsule
  • Physical Form: Encapsulated solid
  • Solubility: Suitable for in vitro dissolution studies; consult current literature for solvent compatibility
  • Stability: High enzymatic resistance due to non-peptide molecular structure
  • Molecular Profile: Compact low-molecular-weight scaffold optimized for GLP-1 receptor binding affinity

These physicochemical properties make Orforglipron particularly well-suited for research programs exploring oral incretin receptor engagement, metabolic signaling cascades, and comparative pharmacodynamic modeling against peptide-class GLP-1 agonists.

Purity & Analytical Verification (HPLC & MS)

Every batch of Orforglipron supplied by The Peptide Store is verified to a minimum purity threshold of ≥98%, confirmed through high-performance liquid chromatography (HPLC) and mass spectrometry (MS) analytical methods. HPLC analysis quantifies compound integrity and identifies the presence of any residual impurities, while MS verification confirms the precise molecular weight and structural identity of the active compound. Researchers can rely on this dual-method analytical framework to ensure experimental reproducibility and data integrity across all assay formats.

Quality Control & Lyophilization Integrity

Orforglipron capsules are produced under stringent quality control protocols designed to maintain compound stability throughout the manufacturing, encapsulation, and fulfillment chain. Each capsule is filled to a precise 12mg specification, ensuring dose-to-dose consistency critical for longitudinal research programs. The encapsulated solid format provides a stable, moisture-resistant matrix that preserves compound integrity during transit and laboratory storage. Batch-level quality records are maintained to support traceability and research documentation requirements.

Safety, Handling & Laboratory Precautions

This compound is intended exclusively for qualified researchers operating within properly equipped laboratory environments. Standard laboratory personal protective equipment (PPE) — including nitrile gloves, safety eyewear, and a laboratory coat — should be worn when handling capsules or any derived research preparations. Avoid generating dust or aerosols during handling. Keep the compound away from heat sources, open flames, and incompatible solvents. All waste materials should be disposed of in accordance with applicable institutional and regulatory guidelines. This product is not approved for human or veterinary use and must not be administered to any living organism outside of an approved preclinical research framework.

Reconstitution, Packaging & Storage

Orforglipron is supplied in encapsulated solid form and does not require reconstitution for standard research applications. For in vitro dissolution or solubility studies, researchers should consult peer-reviewed literature for appropriate solvent systems and concentrations. Capsules should be stored in a cool, dry environment away from direct light and humidity. Recommended storage temperature is consistent with ambient laboratory conditions unless otherwise specified by the research protocol. Keep all materials sealed in original packaging until use to maintain compound integrity and prevent contamination.

Intended Research Use & Market Positioning

Orforglipron is positioned as a premier research-grade compound for laboratories conducting advanced investigations into GLP-1 receptor pharmacology, oral incretin mimetics, metabolic syndrome modeling, glycemic regulation, and appetite-signaling pathways. The 90-capsule, 1,080mg total-mass configuration is specifically designed to support extended research timelines, high-throughput screening programs, and multi-cohort preclinical studies. The Peptide Store’s commitment to ≥98% purity and batch-verified quality makes this product a trusted choice for researchers who demand consistency and scientific rigor. Buy Orforglipron online from The Peptide Store and access one of the most structurally advanced oral GLP-1 research tools available today.

Ordering, Availability & Fulfillment

Orforglipron (12mg x 90 Capsules) is available for sale now through The Peptide Store with streamlined online ordering and prompt fulfillment. Our inventory is maintained at scale to support research institutions, independent laboratories, and academic procurement teams. Order now to take advantage of competitive best-price positioning, reliable stock availability, and fast dispatch. All orders are packaged securely to preserve compound integrity during transit. Contact our research support team for bulk order inquiries or institutional pricing arrangements.

Legal & Regulatory Disclaimer

For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications. Orforglipron supplied by The Peptide Store is intended solely for in vitro and preclinical laboratory research conducted by qualified scientific professionals. This product has not been evaluated by any regulatory authority for safety or efficacy in humans or animals. It must not be used as a drug, food supplement, or therapeutic agent. Purchasers are solely responsible for ensuring compliance with all applicable local, national, and international laws governing the procurement, handling, and use of research compounds. The Peptide Store assumes no liability for misuse, improper handling, or non-compliant application of this product.

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “Orforglipron (12mg x 90 Capsules = 1,080mg)”

Your email address will not be published. Required fields are marked *

Shipping & Delivery